Development of Carborane-Based Benzothiazole Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands
Saved in:
| Main Authors: | Lea Ueberham, Aleksandr Kazimir, Winnie Deuther-Conrad, Evamarie Hey-Hawkins |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-08-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.5c06508 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assay
by: Leire Borrega-Roman, et al.
Published: (2025-04-01) -
Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potential
by: Christoph Selg, et al.
Published: (2024-12-01) -
Synthesis, Analytical Characterization, and Human CB<sub>1</sub> Receptor Binding Studies of the Chloroindole Analogues of the Synthetic Cannabinoid MDMB-CHMICA
by: Sascha Münster-Müller, et al.
Published: (2024-11-01) -
Synthesis and Anticancer Activity Evaluation of Novel Carborane-Containing Isoflavonoid Analogues
by: Yirong Zhang, et al.
Published: (2025-04-01) -
Association of Cannabinoid CB2 Receptor Q63R Variant With Rheumatoid Arthritis in an Iranian Cohort
by: Ali Nateghi, et al.
Published: (2025-01-01)